https://scholars.lib.ntu.edu.tw/handle/123456789/567535| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Chen W.-C. | en_US |
| dc.contributor.author | Lee C.-C. | en_US |
| dc.contributor.author | Chien M.-N. | en_US |
| dc.contributor.author | Liu S.-C. | en_US |
| dc.contributor.author | Wang C.-H. | en_US |
| dc.contributor.author | WEI-SHIUNG YANG | en_US |
| dc.date.accessioned | 2021-07-02T02:35:16Z | - |
| dc.date.available | 2021-07-02T02:35:16Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.issn | 1873-9598 | - |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048874210&doi=10.1016%2fj.ijge.2018.05.008&partnerID=40&md5=feee24afda74156adf074e11c437a34f | - |
| dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/567535 | - |
| dc.description.abstract | With the increasing number of aged individuals in the population and the elevated prevalence of diabetes worldwide, there are more and older people with type 2 diabetes. Unfortunately, the management of diabetes in the elderly is not easy. Older people are heterogeneous. Hypoglycemia and hyperglycemia crises are more frequent and dangerous to older patients. Comorbidities, functional impairment and the available support system may influence the management of the disease. The target of glycemic control in the elderly should be based on individual conditions. Although the number of clinical trials relating to the management of type 2 diabetes in the elderly is limited, organizations have provided guidelines or statements about type 2 diabetes in the elderly. There are approved therapies or medicines for type 2 diabetes controls, but we should have more considerations for aged patients with type 2 diabetes. ? 2018 | - |
| dc.publisher | Elsevier (Singapore) Pte Ltd | - |
| dc.relation.ispartof | International Journal of Gerontology | - |
| dc.subject | aged; type 2 diabetes | - |
| dc.subject.other | 2,4 thiazolidinedione derivative; alpha glucosidase inhibitor; dipeptidyl peptidase IV inhibitor; glucagon like peptide 1 receptor agonist; glucose; insulin; meglitinide; metformin; sodium glucose cotransporter 2 inhibitor; sulfonylurea; aged; blood glucose monitoring; comorbidity; evidence based practice; functional disease; geriatric disorder; glucose blood level; glycemic control; human; hyperglycemia; hypoglycemia; multicenter study (topic); non insulin dependent diabetes mellitus; polypharmacy; practice guideline; priority journal; randomized controlled trial (topic); Review; social support; treatment indication | - |
| dc.subject.other | [SDGs]SDG3 | - |
| dc.title | Blood Glucose Management of Type 2 Diabetes in the Older People | en_US |
| dc.type | Review | - |
| dc.identifier.doi | 10.1016/j.ijge.2018.05.008 | - |
| dc.identifier.scopus | 2-s2.0-85048874210 | - |
| dc.relation.pages | 170-174 | - |
| dc.relation.journalvolume | 12 | - |
| dc.relation.journalissue | 3 | - |
| item.grantfulltext | none | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.openairetype | Review | - |
| item.fulltext | no fulltext | - |
| item.cerifentitytype | Publications | - |
| crisitem.author.dept | Clinical Medicine | - |
| crisitem.author.orcid | 0000-0001-5087-373X | - |
| crisitem.author.parentorg | College of Medicine | - |
| Appears in Collections: | 醫學系 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.